Crewe Advisors’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-35
Closed -$3.31K 651
2024
Q3
$3.31K Hold
35
﹤0.01% 603
2024
Q2
$3.34K Hold
35
﹤0.01% 848
2024
Q1
$4.61K Buy
+35
New +$4.31K ﹤0.01% 744
2023
Q3
Sell
-1
Closed -$224 600
2023
Q2
$224 Buy
+1
New +$205 ﹤0.01% 698
2023
Q1
Sell
-19
Closed -$4.12K 817
2022
Q4
$4.12K Sell
19
-20
-51% -$5.33K ﹤0.01% 709
2022
Q3
$10K Buy
39
+4
+11% +$1.02K ﹤0.01% 648
2022
Q2
$7K Buy
+35
New +$7.81K ﹤0.01% 676
2018
Q3
Sell
-60
Closed -$6K 234
2018
Q2
$6K Buy
60
+10
+20% +$960 0.01% 226
2018
Q1
$5K Buy
+50
New +$5.51K ﹤0.01% 236

Other funds holding ALB

Crewe Advisors's ALB Position: Q4 2024 in Review

Crewe Advisors sold out of Albemarle (ALB) in Q4 2024, closing a stake of 35 shares — an estimated $3.31K sold.

Crewe Advisors first reported a position in ALB in Q1 2018 and held it in 9 quarters. The position peaked at $10K in Q3 2022. 805 funds tracked by Wall St. Rank hold ALB as of Q4 2024.

  • Crewe Advisors reported no remaining Albemarle position as of Q4 2024 after selling out during the quarter.
  • Crewe Advisors sold 35 Albemarle shares in Q4 2024, an estimated $3.31K.
  • Crewe Advisors first reported a position in Albemarle in Q1 2018 and held it in 9 quarters.
  • Crewe Advisors's Albemarle position peaked at $10K in Q3 2022.
  • 805 funds tracked by Wall St. Rank held Albemarle as of Q4 2024.

Based on Crewe Advisors's 13F filing for Q4 2024, filed 27 Jan 2025.